Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P30279: Variant p.Thr280Ala

G1/S-specific cyclin-D2
Gene: CCND2
Feedback?
Variant information Variant position: help 280 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Threonine (T) to Alanine (A) at position 280 (T280A, p.Thr280Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (T) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In MPPH3. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 280 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 289 The length of the canonical sequence.
Location on the sequence: help QYRQDQRDGSKSEDELDQAS T PTDVRDIDL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         QYRQ--DQRD-GSKSEDELDQASTPTDVRDIDL

Mouse                         QFRQ--EQHNAGSKSVEDPDQATTPTDVRD

Rat                           QFRQ--EQHN-GSKSVEDPDQATTPTDVRD

Pig                           QYRQ--DQ-D-GSKSEDELDQASTPTDVRD

Bovine                        QYRQ--DQGD-GSKSEDELDQASTPTDVRD

Chicken                       QVRQQQQQSN-PSKTIEELDQASTPTDVRD

Xenopus laevis                QTRQQTQQRN-SSKSVDELDQASTPTDVQD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 289 G1/S-specific cyclin-D2
Region 264 – 289 Disordered
Compositional bias 265 – 289 Basic and acidic residues
Modified residue 271 – 271 Phosphoserine
Modified residue 280 – 280 Phosphothreonine
Alternative sequence 210 – 289 Missing. In isoform 2.



Literature citations
De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.
Mirzaa G.M.; Parry D.A.; Fry A.E.; Giamanco K.A.; Schwartzentruber J.; Vanstone M.; Logan C.V.; Roberts N.; Johnson C.A.; Singh S.; Kholmanskikh S.S.; Adams C.; Hodge R.D.; Hevner R.F.; Bonthron D.T.; Braun K.P.; Faivre L.; Riviere J.B.; St-Onge J.; Gripp K.W.; Mancini G.M.; Pang K.; Sweeney E.; van Esch H.; Verbeek N.; Wieczorek D.; Steinraths M.; Majewski J.; Boycott K.M.; Pilz D.T.; Ross M.E.; Dobyns W.B.; Sheridan E.G.;
Nat. Genet. 46:510-515(2014)
Cited for: INVOLVEMENT IN MPPH3; VARIANTS MPPH3 ASN-280; ALA-280; ARG-281; LEU-281 AND GLY-284;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.